HMGB1 Mediates the Development of Tendinopathy Due to Mechanical Overloading

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Sep 28

PMID 31560698

Citations 15

Authors

Guangyi Zhao

Jianying Zhang

Daibang Nie

Yiqin Zhou

Feng Li

Kentaro Onishi

Timothy Billiar

James H-C Wang

Affiliations

Soon will be listed here.

Abstract

Mechanical overloading is a major cause of tendinopathy, but the underlying pathogenesis of tendinopathy is unclear. Here we report that high mobility group box1 (HMGB1) is released to the tendon extracellular matrix and initiates an inflammatory cascade in response to mechanical overloading in a mouse model. Moreover, administration of glycyrrhizin (GL), a naturally occurring triterpene and a specific inhibitor of HMGB1, inhibits the tendon's inflammatory reactions. Also, while prolonged mechanical overloading in the form of long-term intensive treadmill running induces Achilles tendinopathy in mice, administration of GL completely blocks the tendinopathy development. Additionally, mechanical overloading of tendon cells in vitro induces HMGB1 release to the extracellular milieu, thereby eliciting inflammatory and catabolic responses as marked by increased production of prostaglandin E2 (PGE2) and matrix metalloproteinase-3 (MMP-3) in tendon cells. Application of GL abolishes the cellular inflammatory/catabolic responses. Collectively, these findings point to HMGB1 as a key molecule that is responsible for the induction of tendinopathy due to mechanical overloading placed on the tendon.

Citing Articles

Treatment options for Achilles tendinopathy: a scoping review of preclinical studies.

Agyeman-Prempeh N, Maas H, Burchell G, Millar N, Moen M, Smit T PeerJ. 2025; 13():e18143.

PMID: 39807157 PMC: 11727660. DOI: 10.7717/peerj.18143.

Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography.

Maloney D, Zhang J, Bhargava S, Hogan M, Wang J Bioanalysis. 2024; 16(21-22):1115-1124.

PMID: 39411983 PMC: 11583596. DOI: 10.1080/17576180.2024.2412438.

Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers.

Zhang J, Shimozaki K, Hattori S, Pastukh V, Maloney D, Hogan M PLoS One. 2024; 19(9):e0311147.

PMID: 39331598 PMC: 11433050. DOI: 10.1371/journal.pone.0311147.

Mitigating Scar Tissue Formation in Tendon Injuries: Targeting HMGB1, AMPK Activation, and Myofibroblast Migration All at Once.

Zhang J, Brown R, Hogan M, Wang J Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139865 PMC: 10748062. DOI: 10.3390/ph16121739.

Animal model for tendinopathy.

Luo J, Wang Z, Tang C, Yin Z, Huang J, Ruan D J Orthop Translat. 2023; 42:43-56.

PMID: 37637777 PMC: 10450357. DOI: 10.1016/j.jot.2023.06.005.

References

Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A . HMGB1: endogenous danger signaling. Mol Med. 2008; 14(7-8):476-84. PMC: 2323334. DOI: 10.2119/2008-00034.Klune. View

Wahamaa H, Schierbeck H, Hreggvidsdottir H, Palmblad K, Aveberger A, Andersson U . High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther. 2011; 13(4):R136. PMC: 3239379. DOI: 10.1186/ar3450. View

Jarvinen T, Kannus P, Maffulli N, Khan K . Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin. 2005; 10(2):255-66. DOI: 10.1016/j.fcl.2005.01.013. View

Lipman K, Wang C, Ting K, Soo C, Zheng Z . Tendinopathy: injury, repair, and current exploration. Drug Des Devel Ther. 2018; 12:591-603. PMC: 5865563. DOI: 10.2147/DDDT.S154660. View

Zhang J, Wang J . BMP-2 mediates PGE(2) -induced reduction of proliferation and osteogenic differentiation of human tendon stem cells. J Orthop Res. 2011; 30(1):47-52. PMC: 3189415. DOI: 10.1002/jor.21485. View

Akbar M, Gilchrist D, Kitson S, Nelis B, Crowe L, Garcia-Melchor E . Targeting danger molecules in tendinopathy: the HMGB1/TLR4 axis. RMD Open. 2017; 3(2):e000456. PMC: 5574425. DOI: 10.1136/rmdopen-2017-000456. View

Battery L, Maffulli N . Inflammation in overuse tendon injuries. Sports Med Arthrosc Rev. 2011; 19(3):213-7. DOI: 10.1097/JSA.0b013e31820e6a92. View

Andersson U, Tracey K . HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011; 29:139-62. PMC: 4536551. DOI: 10.1146/annurev-immunol-030409-101323. View

Venereau E, Schiraldi M, Uguccioni M, Bianchi M . HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol. 2012; 55(1):76-82. DOI: 10.1016/j.molimm.2012.10.037. View

10.

Mosca M, Carr A, Snelling S, Wheway K, Watkins B, Dakin S . Differential expression of alarmins-S100A9, IL-33, HMGB1 and HIF-1α in supraspinatus tendinopathy before and after treatment. BMJ Open Sport Exerc Med. 2017; 3(1):e000225. PMC: 5530124. DOI: 10.1136/bmjsem-2017-000225. View

11.

Akamatsu H, Komura J, Asada Y, Niwa Y . Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med. 1991; 57(2):119-21. DOI: 10.1055/s-2006-960045. View

12.

Fu Y, Zhou E, Wei Z, Liang D, Wang W, Wang T . Glycyrrhizin inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model. FEBS J. 2014; 281(11):2543-57. DOI: 10.1111/febs.12801. View

13.

Tang D, Kang R, Zeh 3rd H, Lotze M . High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2010; 14(7):1315-35. PMC: 3048826. DOI: 10.1089/ars.2010.3356. View

14.

Wang H, Bloom O, Zhang M, Vishnubhakat J, Ombrellino M, Che J . HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999; 285(5425):248-51. DOI: 10.1126/science.285.5425.248. View

15.

Andersson U, Harris H . The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta. 2010; 1799(1-2):141-8. DOI: 10.1016/j.bbagrm.2009.11.003. View

16.

Genovese T, Menegazzi M, Mazzon E, Crisafulli C, Di Paola R, Dal Bosco M . Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock. 2008; 31(4):367-75. DOI: 10.1097/SHK.0b013e3181833b08. View

17.

van Rossum T, Vulto A, de Man R, Brouwer J, Schalm S . Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther. 1998; 12(3):199-205. DOI: 10.1046/j.1365-2036.1998.00309.x. View

18.

Yang H, Wang H, Chavan S, Andersson U . High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule. Mol Med. 2015; 21 Suppl 1:S6-S12. PMC: 4661054. DOI: 10.2119/molmed.2015.00087. View

19.

Spiesz E, Thorpe C, Chaudhry S, Riley G, Birch H, Clegg P . Tendon extracellular matrix damage, degradation and inflammation in response to in vitro overload exercise. J Orthop Res. 2015; 33(6):889-97. PMC: 4855636. DOI: 10.1002/jor.22879. View

20.

Riley G . Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev Mol Med. 2005; 7(5):1-25. DOI: 10.1017/S1462399405008963. View